中山大学孙逸仙纪念医院，又名中山大学附属第二医院，是一家院本部位于广东省广州市越秀区的三级甲等医院，隶属于中山大学，由中华人民共和国国家卫生健康委员会直管。 该院于清道光十五年由美国传教士伯驾创立，原称博济医院，是中国第一家西医医院。1886年孙中山曾于此学医和从事革命活动。

During the past decade, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University conducted 268 clinical trials. In the 10-year time frame, 268 clinical trials started and 24 clinical trials were completed, i.e. on average, 9% percent of trials that started reached the finish line to date. In the past 5 years, 198 clinical trials started and 21 clinical trials were completed. i.e. 10.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University" #1 sponsor was "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University" with 108 trials, followed by "Sun Yat-sen University" with 20 trials sponsored, "Eli Lilly and Company" with 12 trials sponsored, "BeiGene" with 11 trials sponsored and "Jiangsu HengRui Medicine Co., Ltd." with 11 trials sponsored. Other sponsors include 132 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University" #1 collaborator was "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University" with 19 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 10 trials as a collaborator, "Sun Yat-sen University" with 9 trials as a collaborator, "The First Affiliated Hospital with Nanjing Medical University" with 8 trials as a collaborator and "Third Affiliated Hospital, Sun Yat-Sen University" with 8 trials as a collaborator. Other collaborators include 419 different institutions and companies that were collaborators in the rest 252 trials.

According to Clinical.Site data, the most researched conditions in "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University" are "Breast Cancer" (36 trials), "Nasopharyngeal Carcinoma" (8 trials), "Bladder Cancer" (7 trials), "Breast Neoplasms" (6 trials) and "Metastatic Breast Cancer" (6 trials). Many other conditions were trialed in "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University" in a lesser frequency.

Most popular intervention types in "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University" are "Drug" (211 trials), "Other" (32 trials), "Procedure" (30 trials), "Device" (10 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Docetaxel" (8 trials), "Gemcitabine" (8 trials), "Capecitabine" (7 trials) and "Tislelizumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University" are 208 trials for "All" genders, 76 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 186 active trials in "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University". 21 are not yet recruiting, 126 are recruiting, 36 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 59 completed trials in Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 28 "Phase 1" clinical trials were conducted, 84 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 33 trials that are defined as “Not Applicable".

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University has several departments that took part in Clinical trials: "Department of Radiology" - 8 trials, "Department of Cardiology, the Third Affiliated Hospital, Sun Yat-sen University" - 2 trials